Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H3ClN2O2 |
| Molecular Weight | 146.532 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CNC(=O)NC1=O
InChI
InChIKey=ZFTBZKVVGZNMJR-UHFFFAOYSA-N
InChI=1S/C4H3ClN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Interaction of monoclonal antibodies directed against bromodeoxyuridine with pyrimidine bases, nucleosides, and DNA. | 1986 Mar 1 |
|
| Structure-activity relationship of ligands of uracil phosphoribosyltransferase from Toxoplasma gondii. | 1994 Aug 17 |
|
| Simultaneous determination of flucytosine and fluorouracil in human plasma by high-performance liquid chromatography. | 2001 Apr |
|
| 5-Chlorouracil, a marker of DNA damage from hypochlorous acid during inflammation. A gas chromatography-mass spectrometry assay. | 2003 Aug 29 |
|
| Phagocytes produce 5-chlorouracil and 5-bromouracil, two mutagenic products of myeloperoxidase, in human inflammatory tissue. | 2003 Jun 27 |
|
| Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies. | 2004 Aug 1 |
|
| Influence of halogenation on the properties of uracil and its noncovalent interactions with alkali metal ions. Threshold collision-induced dissociation and theoretical studies. | 2004 Dec 15 |
|
| Synthesis and characterization of oligonucleotides containing 5-chlorocytosine. | 2004 Sep |
|
| Measurement of drug release from microcarriers by microdialysis. | 2005 Jul |
|
| Hydrophilic interaction liquid chromatography-APCI-mass spectrometry determination of 5-fluorouracil in plasma and tissues. | 2005 Jul 15 |
|
| [Clinical benefit of S-1 in metastatic breast cancer]. | 2006 Jun |
|
| Significance of 5-fluorouracil-related enzyme activities in predicting sensitivity to 5-fluorouracil in bladder carcinoma. | 2009 Apr |
|
| Reactive oxygen and nitrogen species induce protein and DNA modifications driving arthrofibrosis following total knee arthroplasty. | 2009 Nov 13 |
|
| [Markers of chloric acid (I) in biological systems--identification and properties]. | 2010 |
|
| Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/ LV. | 2010 Aug |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1820-81-1
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY | |||
|
15758
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY | |||
|
217-339-7
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY | |||
|
1279054
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY | |||
|
7LQ4V03RNY
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY | |||
|
60762
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY | |||
|
28172
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY | |||
|
DTXSID7075137
Created by
admin on Sat Dec 16 00:42:09 GMT 2023 , Edited by admin on Sat Dec 16 00:42:09 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
